I have said all along that I thought that a big ph
Post# of 72440
And I still think so.
And this makes me very happy that Leo did the shelf registration and new Aspire deal, so that we can continue to develop our drugs and hold out for a fair deal. SOMEONE is going to want Bril-OM and Bril-UP, not to mention the rest of the Brilacidin platform.
As for Prurisol and Kevetrin, we'll see how the clinical trials do, but I feel optimistic that at least one of them will be good.